The Cell and Gene Therapy Catapult will lead a £3 million investment to scale up skills and training in the UK’s life sciences industry.

It will create new skills and capabilities to bridge the gap between the regulatory approval of cell and gene therapies and the integration into front-line services.

The funding comes from UK Research and Innovation through Innovate UK

Read the whole article here.

Submitted on 18/05/2018